- •Contents
- •General Introduction
- •Objectives
- •Anatomy
- •Eyelids
- •Conjunctiva
- •Lacrimal Functional Unit
- •The Tear Film
- •Cornea
- •Sclera
- •2 Examination Techniques for the External Eye and Cornea
- •Evaluation of Vision in the Patient With an Abnormal Cornea
- •External Examination
- •Slit-Lamp Biomicroscopy
- •Direct Illumination Methods
- •Indirect Illumination Methods
- •Clinical Use
- •Stains
- •Fluorescein
- •Rose Bengal and Lissamine Green
- •Evaluation of the Tear Film and Tests of Tear Production
- •Tear Composition Assays
- •Imaging Technologies
- •Impression Cytology
- •Corneal Pachymetry
- •Measurement of Corneal Biomechanics
- •Measurement of Corneal Curvature
- •Zones of the Cornea
- •Shape, Curvature, and Power
- •Keratometry
- •Computerized Corneal Topography
- •Corneal Tomography
- •Indications
- •Ultrasound Biomicroscopy
- •Anterior Segment Optical Coherence Tomography
- •Confocal Microscopy
- •External and Slit-Lamp Photography
- •Specular Microscopy
- •Anterior Segment Fluorescein Angiography
- •Esthesiometry
- •Retinoscopy
- •3 Clinical Approach to Ocular Surface Disorders
- •Common Clinical Findings
- •Conjunctival Signs
- •Corneal Signs
- •Clinical Approach to Dry Eye
- •Mechanisms of Dry Eye
- •Aqueous Tear Deficiency
- •Evaporative Dry Eye
- •Treatment of Dry Eye
- •Rosacea
- •Seborrheic Blepharitis
- •Staphylococcal Blepharitis
- •Hordeola and Chalazia
- •Exposure Keratopathy
- •Floppy Eyelid Syndrome
- •Superior Limbic Keratoconjunctivitis
- •Recurrent Corneal Erosion
- •Neurotrophic Keratopathy and Persistent Corneal Epithelial Defects
- •Trichiasis and Distichiasis
- •Factitious Ocular Surface Disorders
- •Dellen
- •Limbal Stem Cell Deficiency
- •Sjögren Syndrome
- •Ichthyosis
- •Ectodermal Dysplasia
- •Xeroderma Pigmentosum
- •Vitamin A Deficiency
- •4 Infectious Diseases of the External Eye: Basic Concepts and Viral Infections
- •Defense Mechanisms of the External Eye
- •Normal Ocular Flora
- •Pathogenesis of Ocular Infections
- •Virulence
- •Inoculum
- •Host Defense
- •Ocular Microbiology
- •Diagnostic Laboratory Techniques
- •Specimen Collection
- •Staining Methods
- •Virology and Viral Infections
- •DNA Viruses: Herpesviruses
- •Herpes Simplex Eye Diseases
- •Varicella-Zoster Virus Dermatoblepharitis, Conjunctivitis, and Keratitis
- •Epstein-Barr Virus Dacryoadenitis, Conjunctivitis, and Keratitis
- •Cytomegalovirus Keratitis and Anterior Uveitis
- •DNA Viruses: Adenoviruses
- •DNA Viruses: Poxviruses
- •Molluscum Contagiosum
- •Vaccinia
- •DNA Viruses: Papovaviruses
- •RNA Viruses
- •Bacteriology
- •Gram-positive Cocci
- •Gram-negative Cocci
- •Gram-positive Rods
- •Gram-negative Rods
- •Gram-positive Filaments
- •Chlamydia Species
- •Spirochetes
- •Mycology
- •Yeasts
- •Septate Filamentous Fungi
- •Nonseptate Filamentous Fungi
- •Parasitology
- •Protozoa
- •Helminths
- •Arthropods
- •Prions
- •Staphylococcal Blepharitis
- •Fungal and Parasitic Infections of the Eyelid Margin
- •Bacterial Conjunctivitis in Children and Adults
- •Parinaud Oculoglandular Syndrome
- •Microbial and Parasitic Infections of the Cornea and Sclera
- •Contact Lens–Related Infectious Keratitis
- •Bacterial Keratitis
- •Atypical Mycobacteria
- •Fungal Keratitis
- •Acanthamoeba Keratitis
- •Corneal Stromal Inflammation Associated With Systemic Infections
- •Microsporidiosis
- •Loiasis
- •Microbial Scleritis
- •6 Ocular Immunology
- •Overview of the Ocular Surface Immune Response
- •Tear Film
- •Immunoregulation of the Ocular Surface
- •Angiogenesis and Lymphangiogenesis in the Cornea
- •Tissue-Specific Patterns of Immune-Mediated Ocular Disease
- •Conjunctiva
- •Cornea
- •Sclera
- •Diagnostic Approach to Immune-Mediated Ocular Disorders
- •Immune-Mediated Diseases of the Eyelid
- •Contact Dermatoblepharitis
- •Atopic Dermatitis
- •Immune-Mediated Disorders of the Conjunctiva
- •Hay Fever Conjunctivitis and Perennial Allergic Conjunctivitis
- •Vernal Keratoconjunctivitis
- •Atopic Keratoconjunctivitis
- •Ligneous Conjunctivitis
- •Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- •Mucous Membrane Pemphigoid
- •Ocular Graft-vs-Host Disease
- •Other Immune-Mediated Diseases of the Skin and Mucous Membranes
- •Immune-Mediated Diseases of the Cornea
- •Thygeson Superficial Punctate Keratitis
- •Interstitial Keratitis Associated With Infectious Diseases
- •Reactive Arthritis
- •Cogan Syndrome
- •Marginal Corneal Infiltrates Associated With Blepharoconjunctivitis
- •Peripheral Ulcerative Keratitis Associated With Systemic Immune-Mediated Diseases
- •Mooren Ulcer
- •Corneal Transplant Rejection
- •Immune-Mediated Diseases of the Episclera and Sclera
- •Episcleritis
- •Scleritis
- •8 Clinical Approach to Neoplastic Disorders of the Conjunctiva and Cornea
- •Approach to the Patient With a Neoplastic Conjunctival Lesion
- •Management of Patients With Conjunctival Tumors
- •Surgical Treatment
- •Topical Chemotherapy
- •Tumors of Epithelial Origin
- •Benign Epithelial Tumors
- •Preinvasive Epithelial Lesions
- •Malignant Epithelial Lesions
- •Management of Atypical Epithelial Tumors
- •Other Malignant Epithelial Lesions
- •Glandular Tumors of the Conjunctiva
- •Oncocytoma
- •Sebaceous Gland Carcinoma
- •Tumors of Neuroectodermal Origin
- •Benign Pigmented Lesions
- •Preinvasive Pigmented Lesions
- •Malignant Pigmented Lesions
- •Neurogenic and Smooth-Muscle Tumors
- •Vascular and Mesenchymal Tumors
- •Benign Tumors
- •Malignant Tumors
- •Lymphatic and Lymphocytic Tumors
- •Lymphangiectasia and Lymphangioma
- •Lymphoid Hyperplasia
- •Lymphoma
- •Metastatic Tumors
- •9 Basic and Clinical Concepts of Congenital Anomalies of the Cornea, Sclera, and Globe
- •Developmental Anomalies of the Globe and Sclera
- •Cryptophthalmos
- •Microphthalmos
- •Nanophthalmos
- •Blue Sclera
- •Developmental Anomalies of the Anterior Segment
- •Anomalies of Size and Shape of the Cornea
- •Abnormalities of Corneal Structure and/or Clarity
- •Secondary Abnormalities Affecting the Fetal Cornea
- •Intrauterine Keratitis: Bacterial and Syphilitic
- •Congenital Corneal Keloid
- •Congenital Corneal Anesthesia
- •Congenital Glaucoma
- •Birth Trauma
- •Arcus Juvenilis
- •10 Corneal Dystrophies and Ectasias
- •Corneal Dystrophies
- •Epithelial and Subepithelial Dystrophies
- •Bowman Layer Corneal Dystrophies
- •Stromal Corneal Dystrophies: TGFBI Dystrophies
- •Stromal Dystrophies: Non-TGFBI Dystrophies
- •Endothelial Dystrophies
- •Ectatic Disorders
- •Keratoconus
- •Pellucid Marginal Degeneration
- •Keratoglobus
- •11 Systemic Disorders With Corneal Changes
- •Disorders of Carbohydrate Metabolism
- •Mucopolysaccharidoses
- •Diabetes Mellitus
- •Disorders of Lipid Metabolism and Storage
- •Hyperlipoproteinemias
- •Hypolipoproteinemias
- •Sphingolipidoses
- •Mucolipidoses
- •Disorders of Amino Acid Metabolism
- •Cystinosis
- •Tyrosinemia
- •Alkaptonuria
- •Disorders of Protein Metabolism
- •Amyloidosis
- •Disorders of Immunoglobulin Synthesis
- •Noninflammatory Disorders of Connective Tissue
- •Ehlers-Danlos Syndrome
- •Marfan Syndrome
- •Disorders of Nucleotide Metabolism
- •Gout
- •Porphyria
- •Disorders of Mineral Metabolism
- •Wilson Disease
- •Hypercalcemia
- •Hemochromatosis
- •Corneal and External Disease Signs of Systemic Neoplasia
- •Enlarged Corneal Nerves
- •Appendix
- •12 Clinical Approach to Depositions and Degenerations of the Conjunctiva, Cornea, and Sclera
- •Degenerative Changes of the Conjunctiva
- •Age-Related (Involutional) Changes
- •Pinguecula
- •Pterygium
- •Conjunctival Concretions
- •Conjunctival Inclusion Cysts
- •Conjunctivochalasis
- •Conjunctival Vascular Tortuosity and Hyperemia
- •Degenerative Changes in the Cornea
- •Age-Related (Involutional) Changes
- •Epithelial and Subepithelial Degenerations
- •Stromal Degenerations
- •Endothelial Degenerations
- •Scleral Degenerations
- •Drug-Induced Deposition and Pigmentation
- •Corneal Epithelial Deposits
- •Stromal and Descemet Membrane Pigmentation
- •Endothelial Manifestations
- •13 Clinical Aspects of Toxic and Traumatic Injuries of the Anterior Segment
- •Injuries Caused by Temperature and Radiation
- •Thermal Burns
- •Ultraviolet Radiation
- •Ionizing Radiation
- •Chemical Injuries
- •Alkali Burns
- •Acid Burns
- •Management of Chemical Injuries
- •Toxic Keratoconjunctivitis From Medications
- •Pathogenesis
- •Clinical Presentation
- •Management
- •Animal and Plant Substances
- •Insect Injuries
- •Vegetation Injuries
- •Concussive Trauma
- •Subconjunctival Hemorrhage
- •Corneal Changes
- •Traumatic Mydriasis and Miosis
- •Traumatic Iritis
- •Iridodialysis and Cyclodialysis
- •Traumatic Hyphema
- •Nonperforating Mechanical Trauma
- •Conjunctival Laceration
- •Conjunctival Foreign Body
- •Corneal Foreign Body
- •Corneal Abrasion
- •Perforating Trauma
- •Evaluation
- •Management
- •Surgical Trauma
- •Corneal Epithelial Changes From Intraocular Surgery
- •Descemet Membrane Changes During Intraocular Surgery
- •Corneal Endothelial Changes From Intraocular Surgery
- •Conjunctival and Corneal Changes From Extraocular Surgery
- •14 Treatment of Ocular Surface Disorders
- •Surgical Procedures of the Ocular Surface
- •Limbal Transplantation
- •Autologous Conjunctival Transplantation
- •Pterygium Excision
- •Mucous Membrane Grafting
- •Conjunctival Flap
- •Conjunctival Biopsy
- •Conjunctivochalasis Excision
- •Therapeutic Interventions for Corneal Disease
- •Superficial Keratectomy and Corneal Biopsy
- •Management of Descemetocele, Corneal Perforation, and Corneal Edema
- •Corneal Tattoo
- •Tarsorrhaphy
- •15 Clinical Approach to Corneal Transplantation
- •Corneal Transplantation
- •Eye Banking and Donor Selection
- •Criteria Contraindicating Donor Cornea Use
- •Surgical Approach to Corneal Disease
- •Preoperative Evaluation and Preparation
- •Penetrating Keratoplasty
- •Surgical Technique for Penetrating Keratoplasty
- •Combined Procedures
- •Intraoperative Complications
- •Postoperative Care and Complications
- •Control of Postoperative Corneal Astigmatism and Refractive Error
- •Diagnosis and Management of Graft Rejection
- •Pediatric Corneal Transplantation
- •Corneal Autograft Procedures
- •Keratoprosthesis
- •Lamellar Keratoplasty
- •Anterior Lamellar Transplantation
- •Surgical Technique
- •Postoperative Care and Complications
- •Endothelial Keratoplasty
- •DSEK Surgical Technique and Complications
- •Descemet Membrane Endothelial Keratoplasty
- •Basic Texts
- •Related Academy Materials
- •Requesting Continuing Medical Education Credit
Figure 3-21 Floppy eyelid syndrome with papillary response on superior tarsus. (Courtesy of Vincent P. deLuise, MD.)
Superior Limbic Keratoconjunctivitis
PATHOGENESIS The pathogenesis of superior limbic keratoconjunctivitis (SLK) has not been established, but it is thought to result from mechanical trauma transmitted from the upper eyelid to the superior bulbar and tarsal conjunctiva. An association with autoimmune thyroid disease has been observed.
CLINICAL PRESENTATION SLK is a chronic, recurrent condition of ocular irritation and redness. The condition typically develops in women 20–70 years of age and may recur over a period of 1–10 years. The condition usually resolves spontaneously. It is often bilateral; however, 1 eye may be more severely affected than the other. SLK can be associated with ATD or blepharospasm. Ocular findings may include the following:
a fine papillary reaction on the superior tarsal conjunctiva
injection and thickening of the superior bulbar conjunctiva (Fig 3-22A) hypertrophy of the superior limbus
fine punctate fluorescein and rose bengal staining of the superior bulbar conjunctiva above the limbus and the superior cornea just below the limbus (Fig 3-22B)
superior corneal filamentary keratopathy
Figure 3-22 A, Superior limbic keratoconjunctivitis. B, Rose bengal dye staining pattern in superior limbic
keratoconjunctivitis. (Courtesy of Vincent P. deLuise, MD.)
LABORATORY EVALUATION Hyperproliferation, acanthosis, loss of goblet cells, and keratinization are seen in histologic sections of the superior bulbar conjunctiva. The condition can often be diagnosed by clinical signs. However, scrapings or impression cytology of the superior bulbar conjunctiva showing characteristic features of nuclear pyknosis with “snake nuclei,” increased epithelial cytoplasm–nucleus ratio, loss of goblet cells, or keratinization may be helpful in diagnosing mild or confusing cases. Patients with SLK should undergo thyroid function tests, including tests for free thyroxine (T4), thyroid-stimulating hormone (TSH), and thyroid antibody levels.
MANAGEMENT A variety of therapies have been reported to provide temporary or permanent relief of
symptoms. Treatments include topical anti-inflammatory agents, large-diameter bandage contact lenses, superior punctal occlusion, thermocauterization of the superior bulbar conjunctiva, resection of the bulbar conjunctiva superior to the limbus, topical cyclosporine, autologous serum eyedrops, amniotic membrane transplant, and conjunctival fixation sutures.
Sahin A, Bozkurt B, Irkec M. Topical cyclosporine A in the treatment of superior limbic keratoconjunctivitis: a long-term followup. Cornea. 2008;27(2):193–195.
Theodore FH, Ferry AP. Superior limbic keratoconjunctivitis. Clinical and pathological correlations. Arch Ophthalmol. 1970;84(4):481–484.
Udell IJ, Kenyon KR, Sawa M, Dohlman CH. Treatment of superior limbic keratoconjunctivitis by thermocauterization of the superior bulbar conjunctiva. Ophthalmology. 1986;93(2):162–166.
Yamada M, Hatou S, Mochizuki H. Conjunctival fixation sutures for refractory superior limbic keratoconjunctivitis. Br J Ophthalmol. 2009;93(12):1570–1571.
Recurrent Corneal Erosion
PATHOGENESIS Recurrent erosions typically occur either in eyes that have suffered a sudden, sharp, abrading injury (eg, fingernail, paper cut, tree branch) or in patients with preexisting epithelial basement membrane dystrophy. The superficial injury produces an epithelial abrasion that heals rapidly, frequently leaving no clinical evidence of damage. After an interval ranging from days to years, symptoms suddenly recur without any obvious precipitating event. Symptoms subside spontaneously in most cases, only to recur periodically. In contrast to shearing injuries, small, superficial lacerating injuries involving the cornea rarely result in recurrent erosions. Poor adhesion of the epithelium is thought to be caused by underlying abnormalities in the epithelial basement membrane and its associated filament network. The precise nature of these abnormalities has yet to be fully determined.
Gelatinase activity (MMP-2 and MMP-9) is upregulated in the epithelium of patients with recurrent corneal erosions. Chronic activation of MMPs may either result from or cause poor epithelial adherence, which leads to the symptoms of recurrent corneal erosion. Some patients with recurrent corneal erosions have been noted to have MGD, and increased levels of MMPs have been observed in the tear film of patients with MGD.
CLINICAL PRESENTATION Recurrent corneal erosions are characterized by the sudden onset of eye pain, usually at night or upon first awakening, accompanied by redness, photophobia, and tearing. Individual episodes may vary in severity and duration. Minor episodes usually last from 30 minutes to several hours; typically the cornea has an intact epithelial surface at the time of examination. More severe episodes may last for several days and are often associated with greater pain, eyelid edema, decreased vision, and extreme photophobia. Many patients seem to suffer from ocular discomfort that is out of proportion to the degree of observable pathology. However, slit-lamp examination using retroillumination can frequently reveal subtle corneal abnormalities (eg, epithelial cysts). The corneal epithelium is loosely attached to the underlying basement membrane and Bowman layer, both at the time of a recurrent attack and between attacks, when the cornea appears to be entirely healed. During an acute attack, the epithelium in the involved area frequently appears heaped up and edematous. Although no frank epithelial defect may be present, significant pooling of fluorescein over the affected area is often visible.
The key to distinguishing between posttraumatic erosion and dystrophic erosion in a patient who has no clear-cut history of superficial trauma is careful examination of the contralateral eye following maximal pupillary dilation. Occasionally, subtle areas of loosely adherent epithelium can be identified by applying gentle pressure with a surgical sponge following instillation of topical anesthetics. The presence of basement membrane changes in the unaffected eye implicates a primary
basement membrane defect in the pathogenesis, whereas the absence of such findings suggests a posttraumatic etiology. Other clinical conditions with associated abnormalities of the epithelial basement membrane include diabetes mellitus and dystrophies of the stroma and Bowman layer (see also the discussion on corneal dystrophies in Chapter 10).
MANAGEMENT Traditional therapy for the acute phase of this condition consists of frequent lubrication with antibiotic ointments and cycloplegia, followed by use of nonpreserved lubricants or hypertonic saline solution (5% sodium chloride) during the day and ointment at bedtime for 6–12 months to promote proper epithelial attachment. Hypertonic agents provide lubrication and may transiently produce an osmotic gradient, drawing fluid from the epithelium and theoretically promoting the adherence of epithelial cells to the underlying tissue. Some patients find hypertonic medications unacceptably irritating, although many others do quite well with this therapy indefinitely. Low-dose oral doxycycline and topical corticosteroids have been shown to be very efficacious. The mode of action is thought to be localized inhibition of MMPs.
Although use of a therapeutic bandage contact lens may be helpful, proper patient education and judicious monitoring are crucial. The ideal therapeutic lens has a flat base curve and high oxygen transmissibility (Dk). New-generation soft contact lenses with surface treatments that decrease bacterial adherence may offer a better safety profile. Concomitant use of a topical broad-spectrum antibiotic 3–4 times daily may reduce the possibility of secondary infection.
Patients with recalcitrant disease should be treated through a sequence of interventions. When consistent conservative management fails to control the symptoms, more invasive surgical therapy may be indicated. In patients with posttraumatic recurrent erosions, anterior stromal micropuncture can be very effective if the area can be identified (Fig 3-23). Using a bent 25-gauge needle, the clinician makes numerous superficial puncture wounds in the involved area, producing firm adhesion between the epithelium and the underlying stroma. This procedure should be used with caution in the visual axis. Rarely is a significant scar visible for more than a few months after this procedure. The treatment may need to be repeated in patients whose condition is at first adequately controlled but who later become symptomatic, usually because the initial area of treatment was inadequate. Histologic studies have revealed that the lesions produced by this procedure create subepithelial scars. Use of diathermy to create similar lesions in experimental animals has shown that the efficacy of these procedures is related to their ability to stimulate the formation of new basement membrane complexes. Polishing with a diamond burr is another alternative in some cases.
Figure 3-23 Anterior stromal puncture. The needle is used to encourage microcicatrization among epithelium, Bowman
layer, and stroma. (Reproduced with permission from Kenyon KR, Wagoner MD. Therapy of recurrent erosion and persistent defects of the corneal epithelium. Focal Points: Clinical Modules for Ophthalmologists. San Francisco: American Academy of Ophthalmology; 1991, module 9. Illustration by Laurel Cook.)
In patients with dystrophic, degenerative, or other severe secondary basement membrane disorder–related recurrent erosions, the procedure of choice is epithelial debridement, which can easily be performed at the slit lamp. Following adequate application of topical anesthetic, loosely adherent epithelium is debrided using a surgical sponge, spatula, or surgical blade. Care must be taken not to damage the underlying Bowman layer. Light application of an ophthalmic diamond burr to Bowman layer in the affected area (outside the visual axis) may be effective in reducing recurrences in resistant cases.
Because a significant amount of discomfort can be expected for 3–4 days following this procedure, the patient will likely be more tolerant if debridement is performed at the time of a painful recurrent episode. Topical antibiotic ointment, cycloplegia, and, in some cases, bandage contact lenses are used until reepithelialization is complete. Oral analgesics are often necessary in the first 24 hours.
Excimer laser phototherapeutic keratectomy is an alternative modality for treating patients with
